US firm Locus Performance Ingredients’ full lines of Ferma and Amphi lactonic and linear sophorolipid biosurfactants have REACH registrations from the European Chemicals Agency (ECHA).
The registrations provide EU formulators with access to multifunctional biosurfactant ingredients that enhance product sustainability and performance, the Ohio company said.
The European expansion of Locus’ sophorolipids will be driven by industry expert, Ronald Lieffering.
Lieffering has 35+ years of strong international business management and development experience in specialty and commodity chemicals—including a published patent.
His CV includes R&D and leadership roles at top specialty chemical companies. Based in the Netherlands, Lieffering will act as Locus’s vice president for Europe, the Middle East and Africa (EMEA).
“The specialty chemical market is rapidly evolving towards more sustainable offerings, and green chemistries like biosurfactants are the future,” said Lieffering.
“Locus Performance Ingredients’ sophorolipids have unmatched multifunctionality and impressive mechanisms of action. They are a true game-changer for clean-label formulations across all CPG and industrial formulations throughout Europe, and the rest of the world.”
Locus PI’s sophorolipids belong to the glycolipid class of biosurfactants and provide unique multifunctionality benefits to formulators.
They are said to enhance performance at minimal usage rates to keep formulation costs low and reduce formulation complexity.
“The REACH registrations encompass our full range of sophorolipids,” added Lieffering.
“This allows product formulators to use Locus Performance Ingredients’ complete lines of lactonic and linear sophorolipids, and customize them to meet their needs in a wide variety of applications.”